Regional Anesthesia in Patients on Anticoagulation Therapies—Evidence-Based Recommendations

Purpose of Review Anticoagulant use among patients is prevalent and increasing. It is important for anesthesiologists to be aware of patients on anticoagulants while performing regional anesthesia. Recent Findings In recent years, the FDA has approved many new anticoagulants. With new drugs coming t...

Full description

Saved in:
Bibliographic Details
Published inCurrent pain and headache reports Vol. 23; no. 9; pp. 67 - 7
Main Authors Kaye, Alan David, Brunk, Andrew J., Kaye, Aaron J., Renschler, Jordan S., Hart, Brendon M., Anandi, Prathima, Patil, Shilpa, Cornett, Elyse M., Fox, Charles J.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.09.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose of Review Anticoagulant use among patients is prevalent and increasing. It is important for anesthesiologists to be aware of patients on anticoagulants while performing regional anesthesia. Recent Findings In recent years, the FDA has approved many new anticoagulants. With new drugs coming to the market, new side effect profiles should be considered when treating patients, especially when using regional anesthesia. Both ASRA and European agencies have laid out recommendations regarding anticoagulant use and neuraxial/regional techniques. Regarding newer anticoagulants, the guidelines for discontinuation prior to neuraxial injection are based on pharmacokinetics, including half-life duration for each drug. Summary While each clinical scenario requires an individualized approach, general guidelines can serve as a starting point to help with anesthetic planning and potentially improve patient safety in this evolving field.
ISSN:1531-3433
1534-3081
DOI:10.1007/s11916-019-0805-x